Baltimore, MD, United States of America

Michael Goggins

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Inventor Michael Goggins

Introduction

Michael Goggins, a prominent inventor based in Baltimore, MD, has made significant contributions to the field of medical diagnostics. With a remarkable portfolio of six patents, Goggins focuses on groundbreaking methodologies that enhance the detection and understanding of various cancers.

Latest Patents

Among his latest innovations, Goggins has developed a patent for "Telomere fusions and their detection of dysplasia and/or cancer." This invention describes telomere fusion assays designed to detect dysplasia in subjects, specifically using nested primers. A notable application of this method includes its ability to identify dysplasia in individuals with intraductal papillary mucinous neoplasms (IPMNs). Another significant patent is for a "Diagnostic method using PALB2," which provides a novel approach for detecting mutations in the PALB2 gene in pancreatic cancer patients and those with a familial history of the disease. This invention not only facilitates the diagnosis of predisposition to pancreatic cancer but also predicts a patient's response to therapies and offers pathways for treatment based on PALB2 mutation presence or aberrant gene expression.

Career Highlights

Michael Goggins' career has been marked by his association with The Johns Hopkins University, a prestigious institution known for its dedication to research and innovation. His work at the university has positioned him at the forefront of cancer research, where he is tasked with merging scientific inquiry with practical applications for patient care.

Collaborations

Throughout his career, Goggins has collaborated with notable figures in the field, including Norihiro Sato and Bert Vogelstein. These partnerships have enabled him to enhance the impact of his research and contribute to a broader understanding of cancer diagnostics and treatment.

Conclusion

Michael Goggins stands as a beacon of innovation in medical science, particularly in the realm of cancer diagnosis and treatment. His patents not only advance the scientific community's knowledge but also hold the potential for significant improvements in patient outcomes. As researchers continue to build upon his work, Goggins' contributions are likely to resonate within the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…